Cholesterol / Triglycerides

Nevirapine-based HAART Increases HDL ("Good") Cholesterol in Patients with Sustained HIV Suppression - 8/31/07

Consumption of Saturated Fat Linked to Elevated Triglycerides in HIV Positive People with Metabolic Abnormalities   - 8/17/07

Switching from Efavirenz (Sustiva) to Nevirapine (Viramune) Decreases LDL Cholesterol Levels in Patients with Dyslipidemia    - 7/10/07

Fish Oil Lowers Triglyceride Levels in People with HIV  - 4/10/07

Ezetimibe (Zetia) May Benefit HIV Positive Patients Unable to Take Statins to Lower LDL Cholesterol  - 3/09/07

High Dietary Fat Consumption Is Associated with Elevated Serum Lipids in HIV Positive Individuals  - 3/16/07


Pravastatin, Ezetimibe, and Acipimox in the Management of Metabolic Complications in People with HIV  12/12/06

Switching from Lopinavir/Ritonavir to Unboosted Atazanavir Lowers Lipids - 9/01/06

Effects of Efavirenz- and Atazanavir-based Regimens on HDL Cholesterol - 8/29/06

Lopinavir/Ritonavir Demonstrates Significantly Greater Reduction in HIV RNA Than Unboosted Atazanavir in Patients with Prior Protease Inhibitor Failure - 10/31/05

Fat Loss and Fat Accumulation in HIV Patients Are Distinct Syndromes with No Common Factor Underlying Their Prevalence - 6/24/05

Lopinavir/ritonavir Combination and Total/HDL Cholesterol Ratio - 4/04/05